268 related articles for article (PubMed ID: 32022328)
1. HJC0152 suppresses human non-small-cell lung cancer by inhibiting STAT3 and modulating metabolism.
Lu L; Li H; Wu X; Rao J; Zhou J; Fan S; Shen Q
Cell Prolif; 2020 Mar; 53(3):e12777. PubMed ID: 32022328
[TBL] [Abstract][Full Text] [Related]
2. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
[TBL] [Abstract][Full Text] [Related]
3. MMPP Attenuates Non-Small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity
Son DJ; Zheng J; Jung YY; Hwang CJ; Lee HP; Woo JR; Baek SY; Ham YW; Kang MW; Shong M; Kweon GR; Song MJ; Jung JK; Han SB; Kim BY; Yoon DY; Choi BY; Hong JT
Theranostics; 2017; 7(18):4632-4642. PubMed ID: 29158850
[No Abstract] [Full Text] [Related]
4. Raddeanin A induced apoptosis of non-small cell lung cancer cells by promoting ROS-mediated STAT3 inactivation.
Li L; Chen M; Li G; Cai R
Tissue Cell; 2021 Aug; 71():101577. PubMed ID: 34146943
[TBL] [Abstract][Full Text] [Related]
5. Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer.
Wang CY; Chao TT; Tai WT; Chang FY; Su WP; Chen YL; Chen PT; Weng CY; Yuan A; Shiau CW; Yu CJ; Chen KF
J Thorac Oncol; 2014 Apr; 9(4):488-96. PubMed ID: 24736071
[TBL] [Abstract][Full Text] [Related]
6. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z
Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957
[TBL] [Abstract][Full Text] [Related]
7. Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways.
Meng LQ; Liu C; Luo YH; Piao XJ; Wang Y; Zhang Y; Wang JR; Wang H; Xu WT; Liu Y; Wu YQ; Sun HN; Han YH; Jin MH; Shen GN; Zang YQ; Li J; Fang NZ; Cui YD; Jin CH
Mol Med Rep; 2018 Feb; 17(2):2626-2634. PubMed ID: 29207064
[TBL] [Abstract][Full Text] [Related]
8. Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer.
Xie C; Zhou X; Liang C; Li X; Ge M; Chen Y; Yin J; Zhu J; Zhong C
J Exp Clin Cancer Res; 2021 Aug; 40(1):266. PubMed ID: 34429133
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the Growth and Invasion of Human Head and Neck Squamous Cell Carcinomas via Regulating STAT3 Signaling and the miR-21/β-catenin Axis with HJC0152.
Wang Y; Wang S; Wu Y; Ren Y; Li Z; Yao X; Zhang C; Ye N; Jing C; Dong J; Zhang K; Sun S; Zhao M; Guo W; Qu X; Qiao Y; Chen H; Kong L; Jin R; Wang X; Zhang L; Zhou J; Shen Q; Zhou X
Mol Cancer Ther; 2017 Apr; 16(4):578-590. PubMed ID: 28138036
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.
Shou J; You L; Yao J; Xie J; Jing J; Jing Z; Jiang L; Sui X; Pan H; Han W
Cancer Lett; 2016 Aug; 379(1):124-33. PubMed ID: 27264264
[TBL] [Abstract][Full Text] [Related]
11. Identification of compound CA-5f as a novel late-stage autophagy inhibitor with potent anti-tumor effect against non-small cell lung cancer.
Zhang L; Qiang P; Yu J; Miao Y; Chen Z; Qu J; Zhao Q; Chen Z; Liu Y; Yao X; Liu B; Cui L; Jing H; Sun G
Autophagy; 2019 Mar; 15(3):391-406. PubMed ID: 30145925
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway.
Yang L; Zhou F; Zhuang Y; Liu Y; Xu L; Zhao H; Xiang Y; Dai X; Liu Z; Huang X; Wang L; Zhao C
Br J Cancer; 2021 Feb; 124(3):645-657. PubMed ID: 33122847
[TBL] [Abstract][Full Text] [Related]
13. Disruption of NADPH homeostasis by total flavonoids from Adinandra nitida Merr. ex Li leaves triggers ROS-dependent p53 activation leading to apoptosis in non-small cell lung cancer cells.
Lan T; He S; Luo X; Pi Z; Lai W; Jiang C; Gan J; Wei S; Wu Z; Yun C; Leng J; Li C
J Ethnopharmacol; 2024 Oct; 332():118340. PubMed ID: 38762212
[TBL] [Abstract][Full Text] [Related]
14. Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer.
Li Y; Sun H; Bai C; Hu Y; Tang J; Zhang Y; Chen J; Zhong Z; He Y; Hu K; Yang J
Int Immunopharmacol; 2024 May; 133():112157. PubMed ID: 38678671
[TBL] [Abstract][Full Text] [Related]
15. Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer.
Zhao Z; Wang Y; Gong Y; Wang X; Zhang L; Zhao H; Li J; Zhu J; Huang X; Zhao C; Yang L; Wang L
J Transl Med; 2022 Nov; 20(1):525. PubMed ID: 36371217
[TBL] [Abstract][Full Text] [Related]
16. The sesquiterpene lactone eupatolide induces apoptosis in non-small cell lung cancer cells by suppressing STAT3 signaling.
Ma X; Wu K; Xu A; Jiao P; Li H; Xing L
Environ Toxicol Pharmacol; 2021 Jan; 81():103513. PubMed ID: 33091599
[TBL] [Abstract][Full Text] [Related]
17. A novel STAT3 inhibitor, HJC0152, exerts potent antitumor activity in glioblastoma.
Li Z; Zhu T; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Guo W; Wang Y; Jing C; Dong J; Zhou J; Zhang L; Shen Q; Zhou X
Am J Cancer Res; 2019; 9(4):699-713. PubMed ID: 31105997
[TBL] [Abstract][Full Text] [Related]
18. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
[TBL] [Abstract][Full Text] [Related]
19. Dihydroartemisinin suppresses STAT3 signaling and Mcl-1 and Survivin expression to potentiate ABT-263-induced apoptosis in Non-small Cell Lung Cancer cells harboring EGFR or RAS mutation.
Yan X; Li P; Zhan Y; Qi M; Liu J; An Z; Yang W; Xiao H; Wu H; Qi Y; Shao H
Biochem Pharmacol; 2018 Apr; 150():72-85. PubMed ID: 29360439
[TBL] [Abstract][Full Text] [Related]
20. Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway.
Wang WJ; Mao LF; Lai HL; Wang YW; Jiang ZB; Li W; Huang JM; Xie YJ; Xu C; Liu P; Li YM; Leung ELH; Yao XJ
Pharmacol Res; 2020 Nov; 161():105129. PubMed ID: 32783976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
